| Title |
pathwayPCA: an R package for integrative pathway analysis with modern PCA methodology and gene selection
|
|---|---|
| Published in |
bioRxiv, April 2019
|
| DOI | 10.1101/615435 |
| Authors | |
| Abstract |
With the advance in high-throughput technology for molecular assays, multi-omics datasets have become increasingly available. However, most currently available pathway analysis software provide little or no functionalities for analyzing multiple types of -omics data simultaneously. In addition, most tools do not provide sample-specific estimates of pathway activities, which are important for precision medicine. To address these challenges, we present pathwayPCA, a unique R package for integrative pathway analysis that utilizes modern statistical methodology including supervised PCA and adaptive elastic-net PCA for principal component analysis. pathwayPCA can analyze continuous, binary, and survival outcomes in studies with multiple covariate and/or interaction effects. We provide three case studies to illustrate pathway analysis with gene selection, integrative analysis of multi-omics datasets to identify driver genes, estimating and visualizing sample-specific pathway activities in ovarian cancer, and identifying sex-specific pathway effects in kidney cancer. pathwayPCA is an open source R package, freely available to the research community. We expect pathwayPCA to be a useful tool for empowering the wide scientific community on the analyses and interpretation of the wealth of multiomics data recently made available by TCGA, CPTAC and other large consortiums. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 12 | 15% |
| Japan | 9 | 11% |
| United Kingdom | 8 | 10% |
| Netherlands | 3 | 4% |
| Spain | 2 | 2% |
| Czechia | 2 | 2% |
| Canada | 2 | 2% |
| Germany | 2 | 2% |
| India | 2 | 2% |
| Other | 14 | 17% |
| Unknown | 26 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 41 | 50% |
| Members of the public | 40 | 49% |
| Practitioners (doctors, other healthcare professionals) | 1 | 1% |